When to Stop Eliquis for Hysterectomy in PAF with Prior TIA
Stop apixaban (Eliquis) 2-3 days (48-72 hours) before hysterectomy, as this is an intermediate-to-high bleeding risk procedure, and do NOT use heparin bridging despite the prior TIA. 1
Bleeding Risk Classification
Hysterectomy is classified as a low-to-moderate bleeding risk procedure in the most recent 2022 CHEST guidelines 1. However, given the surgical nature and potential for significant bleeding, a conservative approach treating it as intermediate-to-high risk is prudent.
Pre-operative Management
Timing of Apixaban Discontinuation
For intermediate-to-high bleeding risk procedures:
- Stop apixaban 2-3 days before surgery (meaning skip 4-6 doses if taking twice daily) 2
- The 2022 CHEST guidelines specifically recommend 2 days off before high-bleed-risk procedures 1
- The FDA label states discontinuation at least 48 hours prior to procedures with moderate-to-high bleeding risk 3
Key consideration: This timing assumes normal renal function. Unlike dabigatran, apixaban dosing intervals do not require adjustment for renal impairment in the perioperative period 1.
No Bridging Required
Critically important: Despite the patient's history of TIA (which increases thromboembolic risk), bridging anticoagulation with heparin is NOT recommended 2, 1. The rapid offset kinetics of apixaban (half-life 7-8 hours) make bridging unnecessary and potentially harmful by increasing bleeding risk without reducing thrombotic events 2.
The 2014 Canadian guidelines explicitly state bridging is not recommended for DOACs unless the drug has been withdrawn longer than recommended AND the patient has very high thrombotic risk 2. Even with prior TIA within 3 months being considered high-risk for warfarin bridging decisions, this does not apply to DOAC management 2.
Post-operative Management
Resumption Timing
Resume apixaban 48-72 hours after surgery once adequate hemostasis is established 2:
- The 2022 CHEST guidelines recommend at least 24 hours after low-to-moderate-bleed-risk procedures 1
- For hysterectomy specifically, aim for the 48-72 hour window given the surgical nature 2
- The FDA label states restart "as soon as adequate hemostasis has been established" 3
Dosing Strategy
Consider reduced-dose initiation in this high-risk patient:
- Start with apixaban 2.5 mg twice daily for the first 2-3 days post-operatively 4
- Then increase to full therapeutic dose (5 mg twice daily, or 2.5 mg twice daily if dose-reduction criteria apply) 4
- This graduated approach balances thrombotic risk from the prior TIA against post-operative bleeding risk
Critical Pitfalls to Avoid
Do NOT bridge with heparin - This is outdated practice that increases bleeding without reducing stroke risk 2, 1
Do NOT stop too early - Stopping >3 days before surgery unnecessarily increases stroke risk without additional safety benefit 1
Do NOT resume too quickly - Waiting only 24 hours may be insufficient for hysterectomy; aim for 48-72 hours 2
Check renal function - While apixaban timing doesn't change with renal impairment perioperatively, post-operative renal function changes may require dose adjustment 5
Verify patient compliance - The prior TIA makes stroke prevention critical; confirm the patient actually stopped apixaban as instructed 6
Special Considerations for This Patient
The combination of paroxysmal atrial fibrillation AND prior TIA places this patient at elevated thromboembolic risk. Recent evidence shows apixaban provides significant benefit in patients with subclinical AF and prior stroke/TIA (7% absolute risk reduction over 3.5 years) 7. This underscores the importance of:
- Minimizing the duration of anticoagulation interruption
- Resuming therapeutic anticoagulation as soon as safely possible
- Avoiding unnecessary bridging that increases bleeding risk without reducing stroke risk
The 2-3 day pre-operative interruption with 48-72 hour post-operative resumption represents the optimal balance for this high-risk patient.